This article reads like a press release or a news article and may be largely based on routine coverage. Please help improve this article and add independent sources. (December 2019)
Danaher Corporation
Company typePublic
IndustryConglomerate
Founded
  • 1969; 55 years ago (1969) (as DMG)
  • 1984; 40 years ago (1984) (as Danaher)
FoundersSteven and Mitchell Rales
HeadquartersWashington, D.C., U.S.
Area served
Worldwide
Key people
Steven Rales, Chairman of the Board
Mitchell Rales, Chairman of the Executive Committee
Rainer M. Blair, President & CEO
Matt McGrew, Executive VP & CFO
RevenueDecrease US$23.9 billion (2023)
Decrease US$5.20 billion (2023)
Decrease US$4.76 billion (2023)
Total assetsIncrease US$84.5 billion (2023)
Total equityIncrease US$53.5 billion (2023)
Number of employees
c. 63,000 (2023)
DivisionsList of divisions
Websitedanaher.com
Footnotes / references
[1]
Former logo

Danaher Corporation is an American globally diversified conglomerate founded by brothers Steven and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.[1] It has primarily grown by acquisitions, and historically has tried to maintain a very low public profile.[2][3] Danaher was one of the first companies in North America to adopt the Kaizen principles to manufacturing,[4] which is a lean manufacturing Japanese philosophy of continuous improvement and elimination of waste.[5]

History

Early years

The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and reincorporated in Delaware.[2][1] It was named after Danaher Creek in Western Montana, where the brothers conceptualized it while fishing.[6][2][7]

In June 1986, Danaher purchased Chicago Pneumatic (CP), which had merged in July 1984 with a sister company, the Jacobs Manufacturing Co. (Jacobs), and which had purchased Matco Tools Corp. (MTC) in April 1981.

In June 1987, Danaher sold CP while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.

Within two years of Danaher's founding in 1984, Danaher acquired 12 companies as part of a strategy to enter the manufacturing business. Therefore, in 1986, Danaher added Qualitrol to its instrumentation unit.[8] The unit also included Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors[9] and Qualitrol's pressure and temperature measurement instruments, used on the electrical transformer industry.[10]

The Danaher Motion group acquired Kollmorgen, of Radford, Virginia.[11]

1990–2000

In 1990, Danaher acquired Easco Hand Tools Inc.[12] Danaher was selected as exclusive supplier of handtools for Sears. In 1994, Danaher acquired the tool company Armstrong Tools, the makers of tool brands Armstrong, Allen, and others. In 1995 Danaher acquired German components manufacturer Hengstler, a leading manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition on the European mainland, and the first operating company headquartered outside the United States.[13] Since 1999, Danaher has owned 100% of Hach, broadening the portfolio of chemical, mainly water and wastewater, analytics also with the German company Lange.

2001–2010

Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.[14]

UK-based West Instruments provides control and measurement instrumentation and services for the global industrial and process markets. German instrumentation manufacturer PMA was added to the Industrial Controls Group in 2005 and enhances the range of control and measurement instrumentation.

In July 2005, Danaher announced a definitive agreement to acquire Leica Microsystems.[15] Leica manufactures a broad range of products for numerous applications requiring microscopic imaging, measurement and analysis. It also offers management systems in the areas of Life Science including biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.

In early 2007 Danaher acquired Australian Pathology Instrument and Engineering company Vision Systems Limited.[16] Also in 2007, Danaher made its largest acquisition to date, the purchase of Tektronix, Inc. for US$2.85 billion.[17][18]

ChemTreat was acquired by Danaher in 2007 as well.[19]

In 2009 Danaher purchased the Analytical Technologies business unit of Canadian Life Sciences company MDS, Inc. for US$650 million.[20] In a separate, but related transaction, Danaher agreed with Life Technologies Corporation (Nasdaq: LIFE) to acquire the remaining 50% ownership position in AB SCIEX for US$450 million, leaving Danaher as outright owner of AB SCIEX and Molecular Devices. The aggregate purchase price for the combined transactions is $1.1 billion.[21]

2011–2020

In 2011, Danaher acquired Beckman Coulter[22] and sold Accu-sort to Datalogic.

In October 2012, Danaher and Cooper Industries agreed to sell their joint venture, Apex Tool Group, to Bain Capital for a fee of around $1.6 billion.[23] In December 2012 Danaher Corporation acquired Navman Wireless, a provider of on-demand fleet and asset management technology.[24]

In September 2014, Danaher announced its intention to buy Nobel Biocare for $2.2 billion.[25] In October 2014, Danaher Corp announced it would be combining its communications unit with NetScout Systems.[26] The action was completed in July 2015[27]

In May 2015, Danaher announced the acquisition of Pall Corporation for $13.8 billion,[28] which was completed in August 2015.[29]

In June 2016, Danaher spun off several subsidiaries, including Matco and AMMCO-COATS, to create Fortive.[30] In September of the same year, the company announced it would acquire Cepheid for $4 billion (including debt).[31]

In October 2016, Danaher Corporation acquired Phenomenex for $700 million to expand its life sciences space.[32]

In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS).[33] It was announced that IDBS would become part of Danaher's Life Sciences platform.[34]

In 2017, Danaher recorded $18.3 billion in revenue.[35]

In March 2018, the business announced it would acquire Integrated DNA Technologies for an undisclosed price.[36]

In July 2018, Danaher announced its intention to spin off its $2.8 billion Dental segment into an independent publicly traded company. They named Amir Aghdaei, who at the time was President of Danaher's Dental Platform, to be President and CEO of the new company upon completion of the transaction. [37] The corporate spin-off was completed in December 2019, with the new company called Envista Holdings Corporation.[38]

In October 2019, Danaher announced it has signed an agreement to sell its biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses was approximately $140 million in 2018.[39]

In 2019, Danaher was ranked by Forbes as one of the best employers for diversity.[40]

On Monday, March 2, 2020, Dr. Stephen Hahn, the F.D.A.'s commissioner, said that the agency had taken actions to allow private labs and companies to begin making their own coronavirus tests in order to greatly expand the U.S. capacity to test for the virus. Hahn went on to note, "There will be—the estimates we're getting from industry right now, by the end of this week, close to a million tests will be able to be performed."[41] The following morning, a spokeswoman for the U.S. Department of Health and Human Services noted that Dr. Hahn was referring to tests being produced by an outside manufacturer, Integrated DNA Technologies. IDT is a division of Danaher which was acquired in early 2019.[42]

In March 2020, Danaher acquired the biopharma business of the General Electric Life Sciences division for $21.4 billion and was named Cytiva. Danaher had to sell off part of its life sciences businesses to Sartorius to satisfy the Federal Trade Commission regulatory requirement for the acquisition.[43] Cytiva is a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing.[44][45][46] The Cytiva name stems from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.[47]

In May 2020, it was announced that Tom Joyce would retire as CEO of the company. He was replaced by Executive Vice President Rainier Blair on September 1, 2020.[48]

2021–present

In September 2022, it was announced that Pall Life Sciences will be merging with Cytiva to create a new Biotechnology Group within Danaher. The merger was completed in May 2023.[49][50][51] As of May 2023, Cytiva employed more than 16,000 associates in over 40 countries.[52]

Danaher is set to spin-off its Environmental & Applied Solutions segment in Q4 2023.[53] On February 8, 2023, Danaher announced that the new company is named Veralto Corporation and will be headed by Danaher Executive Vice President Jennifer Honeycutt as President and CEO.[54] On September 30, Danaher announced the separation completion of Veralto and that Veralto will begin trading on the New York Stock Exchange on October 2 under the symbol "VLTO."[55] Based in Waltham, Massachusetts, Veralto's two primary businesses are water testing and treatment, and product labeling and tracing.[56]

On 28 August 2023, Danaher announced that it had entered into a definitive agreement to acquire Abcam for approximately $5.7 billion at $24 per share in cash.[57][58]

Controversies

Further information: Cepheid (company) § Pricing controversy

Controversy has arisen regarding the pricing of test cartridges manufactured by Danaher's subsidiary, Cepheid. These cartridges are essential for detecting diseases such as COVID-19, HIV, and tuberculosis. Organizations such as Treatment Action Group and Doctors Without Borders have been asking Cepheid to lower the price of these tests since 2019.

On September 12, 2023, author and vlogger John Green released a video[59] highlighting these ethical concerns and calling on his community to reach out to Danaher.[60][61] One week later, Cepheid and Danaher announced a 20% price reduction for their Xpert MTB/RIF TB test cartridge, from $9.98 to $7.97 in high TB-burden countries. However, their Xpert MTB/XDR test used to diagnose for drug-resistant TB, which is the deadliest form, remained unchanged at $14.90.[62][63]

Divisions

Life sciences

Diagnostics

Biotechnology

Source: [64]

Former

Tests and measurement

This segment was spun off as Fortive Corporation in July 2016.

Dental

This segment was spun off as Envista Holdings Corporation in December 2019.

Environmental and applied solutions

This segment was spun off as Veralto Corporation in September 2023.

Miscellaneous

See also

References

  1. ^ a b c "Danaher Corporation 2023 Form 10-K Annual Report". U.S. Securities and Exchange Commission. February 21, 2024.
  2. ^ a b c Drummond, Bob (2 April 2004). Takover Wizards, New Zealand Herald
  3. ^ Valdez, Angela (6 June 2008). A Very Private Collection, Washington City Paper
  4. ^ "Fortive and Danaher, Steven and Mitchell Rales". Fortive.
  5. ^ Fox, Justin (19 May 2015). What Makes Danaher Corp. Such a Star?, Bloomberg (discussing kaizen and privacy of company)
  6. ^ "The Danaher Story". Danaher.
  7. ^ Heath, Thomas (7 July 2008). The Quiet Dynamism of the Brothers Rales, The Washington Post
  8. ^ "About the Company". Qualitrol. 2012. Retrieved July 6, 2012.
  9. ^ "Dynapar Motion Control Sensor Rotary Encoders & Resolvers". Dynapar. 2016. Archived from the original on August 9, 2016.
  10. ^ Dubovoj, Sina; Ingram, Frederick (2006). "Danaher Corporation". Resource Library CBS Interactive. Retrieved June 12, 2012.
  11. ^ "Danaher Corp, Form 8-K, Current Report, Filing Date Apr 1, 2003". secdatabase.com. Retrieved March 30, 2013.
  12. ^ "Danaher Acquires Easco Hand Tools". The New York Times. February 21, 1990. Retrieved April 26, 2019.
  13. ^ "Hengstler History". Hengstler.
  14. ^ "Our History". London, ON: Trojan Technologies. Retrieved October 15, 2022.
  15. ^ "Danaher Corp, Form 10-Q, Quarterly Report, Filing Date Jul 21, 2005" (PDF). secdatabase.com. Retrieved March 30, 2013.
  16. ^ "Danaher Corp, Form 10-Q, Quarterly Report, Filing Date Oct 19, 2006". secdatabase.com. Retrieved March 30, 2013.
  17. ^ "Danaher Corp, Form 8-K, Current Report, Filing Date Nov 21, 2007". secdatabase.com. Retrieved March 30, 2013.
  18. ^ "Danaher to Buy Tektronix for $2.85 Billion". The New York Times. October 16, 2007. ISSN 0362-4331. Retrieved April 28, 2015.
  19. ^ Blackwell, John Reid (July 8, 2007). "Buyout enriches workers". Richmond Times-Dispatch. Retrieved January 6, 2021.
  20. ^ "Danaher Corp, Form 10-K, Annual Report, Filing Date Feb 24, 2010" (PDF). secdatabase.com. Retrieved March 29, 2013.
  21. ^ "MDS shares soar on restructuring - the Globe and Mail". www.theglobeandmail.com. Archived from the original on September 2, 2009. Retrieved January 14, 2022.
  22. ^ "Danaher Corp, Form 8-K/A, Filing Date Aug 10, 2011". secdatabase.com. Retrieved March 29, 2013.
  23. ^ "Deals of the day -- mergers and acquisitions". Reuters. October 10, 2012. Archived from the original on September 22, 2013. Retrieved June 30, 2017.
  24. ^ "Danaher Corp Acquires Navman Wireless". Reuters. January 29, 2013.
  25. ^ "Danaher to buy Nobel Biocare for $2.2 billion". Reuters. September 15, 2014.
  26. ^ Danaher to combine communications unit with NetScout Archived 2015-11-27 at the Wayback Machine. Reuters, 14 October 2014
  27. ^ "NetScout Systems, Inc. (NASDAQ: NTCT) has completed the acquisition of Danaher Corporation's (NYSE: DHR) Communications Business. - NetScout.com". Archived from the original on June 6, 2017. Retrieved March 24, 2016.
  28. ^ "Danaher to Acquire Pall for $13.6 Billion and Split Into Two". The New York Times. May 15, 2015. Retrieved April 26, 2019.
  29. ^ "Danaher Completes Acquisition Of Pall Corporation". Pall. Retrieved April 26, 2019.
  30. ^ Zacks Equity Research (July 5, 2016). "Danaher Completes Fortive Spin-Off, Trading to Begin Today". Yahoo Finance. Retrieved July 5, 2016.
  31. ^ "Danaher to Acquire Cepheid for $4B". September 6, 2016.
  32. ^ "Danaher Completes Acquisition Of Phenomenex". biopharma-reporter.com. October 11, 2016. Retrieved November 6, 2016.
  33. ^ "Danaher picks up U.K. data analytics player to boost drug development offerings". FierceBioTech. October 30, 2017. Retrieved December 1, 2017.
  34. ^ "Danaher to Buy U.K. Drug R&D Software Firm ID Business Solutions". Bloomberg.com. October 30, 2017. Retrieved December 1, 2017.
  35. ^ Maake, Katishi (January 7, 2019). "Glenstone Foundation gobbles up more property near its museum". Washington Business Journal. Retrieved January 9, 2019.
  36. ^ "Danaher to Acquire Integrated DNA Technologies". March 9, 2018.
  37. ^ "Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company - Jul 19, 2018". Danaher Corporation Investors.
  38. ^ "Danaher Announces Final Results Of Envista Exchange Offer" (Press release). PR Newswire. December 18, 2019.
  39. ^ Hargreaves, Ben (October 22, 2019). "Sartorius in $750m swoop for Danaher Life Science businesses". Biopharma Reporter. Retrieved October 29, 2019.
  40. ^ "Danaher on the Forbes Best Employers for Diversity List". Forbes.
  41. ^ Thomas, Katie; Sheikh, Knvul (March 3, 2020). "Estimates Fall Short of F.D.A.'s Pledge for 1 Million Coronavirus Tests". The New York Times.
  42. ^ "IDT Leadership".
  43. ^ Macdonald, Gareth John (May 12, 2020). "Sartorius' Acquisition of Danaher Techs Fits Demand for Process Intensification". GEN - Genetic Engineering and Biotechnology News. Retrieved July 9, 2023.
  44. ^ "Cytiva to provide bioprocessing training at Indian incubation centre". cleanroomtechnology.com. Retrieved September 4, 2023.
  45. ^ "BBC collaborates with Cytiva to aid in bioprocessing training programme". biospectrumindia.com. Retrieved September 4, 2023.
  46. ^ "Cytiva". TECHNIA (US). Retrieved September 4, 2023.
  47. ^ "GE Healthcare Life Sciences rebrands to 'Cytiva'". ATMP Sweden. Retrieved September 4, 2023.
  48. ^ "Danaher names next CEO". www.bizjournals.com. Retrieved October 28, 2020.
  49. ^ Stanton, Dan (September 22, 2022). "Danaher merging Cytiva and Pall - BioProcess Insider". BioProcess International.
  50. ^ Stanton, Dan (May 2, 2023). "Danaher completes Cytiva Pall merger - BioProcess Insider". BioProcess International. Retrieved July 9, 2023.
  51. ^ "Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology". Cytiva. May 2, 2023. Retrieved July 9, 2023.
  52. ^ Sterling, John (May 2, 2023). "Merger of Cytiva and Pall's Life Sciences Business Now Complete". GEN - Genetic Engineering and Biotechnology News. Retrieved September 4, 2023.
  53. ^ "Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company - Sep 14, 2022". www.danaher.com.
  54. ^ "Danaher announces new environmental and applied solutions company to be named Veralto". Danaher. February 8, 2023.
  55. ^ Corporation, Danaher (September 30, 2023). "Danaher Corporation Completes Separation of Veralto Corporation". www.prnewswire.com. Archived from the original on October 1, 2023. Retrieved October 1, 2023.
  56. ^ Chesto, Jon (October 2, 2023). "Over the weekend, Greater Boston gained a company on the S&P 500". The Boston Globe. Archived from the original on October 2, 2023.
  57. ^ Mishra, Manas (August 28, 2023). "Danaher to buy Abcam in deal valued at $5.7 billion". Nasdaq. Retrieved August 28, 2023.
  58. ^ "Danaher to Acquire Abcam - Aug 28, 2023". www.danaher.com. August 28, 2023. Retrieved August 28, 2023.
  59. ^ Green, John (September 12, 2023). "Barely Contained Rage: An Open Letter to Danaher and Cepheid" (video). youtube.com. Vlogbrothers.
  60. ^ Baker, Kamrin (September 12, 2023). "John Green & Grassroots Activists Pressure Danaher To Drop Price of Tuberculosis Test". Good Good Good.
  61. ^ Lawrence, Lizzy; Silverman, Ed (September 14, 2023). "Novelist John Green launches attack on Cepheid over the price of its TB test". Stat. Retrieved September 14, 2023.
  62. ^ (19 September 2023). MSF: TB test price reduction by Cepheid and Danaher is a step in the right direction, Doctors Without Borders
  63. ^ Mahdavi, Darius (September 19, 2023). "'Pure price-gouging': Advocates celebrate price drop of critical TB test but say Big Pharma needs to do more". CBC.
  64. ^ "Our Businesses | Danaher". www.danaher.com. Retrieved October 26, 2022.